Fuse Diagnostics has raised £1 million to scale manufacturing and [...]

Novogene Europe has expanded its single-cell RNA sequencing capability at [...]

Pioneer Group has launched regional accelerator programmes in Cambridge and [...]

PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]

ProQR Therapeutics has entered a collaboration with Ginkgo Bioworks to [...]

Abselion has appointed Dale Gordon as chair as the company [...]

Mosaic Therapeutics has appointed Stephen Shuttleworth as chief scientific officer [...]

Shift Bioscience has published new research presenting an improved framework [...]

Enhanced Genomics has secured an additional funding round, bringing its [...]

Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]